What Is In Vitro Fertilization?

In vitro fertilization (IVF) is a medical procedure in which eggs are retrieved from the ovaries, fertilized with sperm in a laboratory environment, and the resulting embryos are cultured before being transferred into the uterus. The term "in vitro" refers to the biological processes occurring outside the body, within controlled laboratory conditions. IVF belongs to the broader category of assisted reproductive technology (ART) and is the most widely used technique for treating infertility arising from a range of causes, including blocked fallopian tubes, male factor infertility, and unexplained cases.

The first successful human birth through IVF occurred in 1978 with Louise Brown, following the work of gynecologist Patrick Steptoe and physiologist Robert Edwards. As documented in a three-decade review published in PMC, the field has since expanded to produce millions of births worldwide and has undergone continuous refinement in pharmacology, embryology, and biomedical engineering.

The IVF Procedure

IVF follows a defined sequence of clinical steps. Controlled ovarian stimulation using gonadotropins prompts the ovaries to produce multiple follicles simultaneously. These follicles are then aspirated through a transvaginal ultrasound-guided needle, a technique that replaced surgical laparoscopy in the 1980s and reduced retrieval time from one to two hours down to approximately fifteen minutes. Retrieved oocytes are examined for maturity and combined with prepared sperm in culture dishes, where fertilization occurs over several hours. Resulting embryos are cultured for three to five days before transfer, typically at the blastocyst stage, into the uterine cavity via a thin catheter.

Embryo Culture and Laboratory Technologies

The laboratory environment in which embryos develop has a direct bearing on outcomes. Culture media, incubator conditions, and physical handling techniques each introduce variables that affect embryo viability. Research highlighted in a bioengineering analysis from PubMed argues that biomechanical factors, including physical forces during transfer and mechanical characterization of oocytes, deserve systematic study alongside chemical culture conditions. Intracytoplasmic sperm injection (ICSI), introduced in 1992, expanded IVF to cases of severe male factor infertility by injecting a single sperm directly into the egg, achieving fertilization rates of roughly 60 to 70 percent. Cryopreservation of surplus embryos has also advanced considerably, enabling frozen-thawed embryo transfers with live birth rates that have converged with those from fresh cycles.

Preimplantation Genetic Testing

Preimplantation genetic testing (PGT) allows embryos to be screened for chromosomal abnormalities or specific gene variants before transfer. First deployed clinically in 1990, PGT has since been refined through whole-genome sequencing and array comparative genomic hybridization, enabling analysis of all 24 chromosomes from a small biopsy of the trophectoderm. The technique is used both to improve implantation rates by selecting euploid embryos and to prevent transmission of hereditary conditions such as cystic fibrosis or sickle-cell disease. Artificial intelligence-assisted embryo grading, as reviewed in research from the Annals of Biomedical Engineering, is increasingly integrated into laboratory workflows to standardize selection decisions that historically relied on subjective morphological scoring.

Applications

In vitro fertilization has applications in a range of clinical and research contexts, including:

• Treatment of infertility caused by tubal, ovulatory, uterine, or male-factor conditions
• Fertility preservation for patients undergoing cancer treatment or elective egg freezing
• Third-party reproduction involving donor eggs, donor sperm, or gestational surrogacy
• Research into early human embryonic development and developmental biology
• Genetic disease prevention through preimplantation genetic testing programs